Patents by Inventor Masafumi Toyoshima

Masafumi Toyoshima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190183857
    Abstract: In one aspect, the invention provides a method for inhibiting the growth and/or proliferation of a myc-driven tumor cell comprising the step of contacting the tumor cells with a CSNK1? inhibitor. In another aspect, the invention provides a method of treating a subject suffering from a tumor comprising myc-driven tumor cells, comprising administering to the subject an amount of a composition comprising a CSNK1? inhibitor effective to inhibit the growth and/or proliferation of the tumor cells.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Inventors: CARLA GRANDORI, MASAFUMI TOYOSHIMA
  • Patent number: 10188630
    Abstract: In one aspect, the invention provides a method for inhibiting the growth and/or proliferation of a myc-driven tumor cell comprising the step of contacting the tumor cells with a CSNK1? inhibitor. In another aspect, the invention provides a method of treating a subject suffering from a tumor comprising myc-driven tumor cells, comprising administering to the subject an amount of a composition comprising a CSNK1? inhibitor effective to inhibit the growth and/or proliferation of the tumor cells.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: January 29, 2019
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Carla Grandori, Masafumi Toyoshima
  • Publication number: 20180153858
    Abstract: In one aspect, the invention provides a method for inhibiting the growth and/or proliferation of a myc-driven tumor cell comprising the step of contacting the tumor cells with a CSNK1? inhibitor. In another aspect, the invention provides a method of treating a subject suffering from a tumor comprising myc-driven tumor cells, comprising administering to the subject an amount of a composition comprising a CSNK1? inhibitor effective to inhibit the growth and/or proliferation of the tumor cells.
    Type: Application
    Filed: September 22, 2017
    Publication date: June 7, 2018
    Inventors: Carla Grandori, Masafumi Toyoshima
  • Publication number: 20180110788
    Abstract: The invention generally relates to methods for identifying and using anticancer therapeutic agents and, more particularly, to methods for identifying and using inhibitors of genes for inhibiting the growth and/or proliferation of MYC-driven tumor cells relative to normal cells.
    Type: Application
    Filed: May 25, 2017
    Publication date: April 26, 2018
    Inventors: Masafumi Toyoshima, Carla Grandori
  • Patent number: 9801853
    Abstract: In one aspect, the invention provides a method for inhibiting the growth and/or proliferation of a myc-driven tumor cell comprising the step of contacting the tumor cells with a CSNK1? inhibitor. In another aspect, the invention provides a method of treating a subject suffering from a tumor comprising myc-driven tumor cells, comprising administering to the subject an amount of a composition comprising a CSNK1? inhibitor effective to inhibit the growth and/or proliferation of the tumor cells.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: October 31, 2017
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Carla Grandori, Masafumi Toyoshima
  • Publication number: 20160367572
    Abstract: The invention generally relates to methods for identifying and using anticancer therapeutic agents and, more particularly, to methods for identifying and using inhibitors of genes for inhibiting the growth and/or proliferation of MYC-driven tumor cells relative to normal cells.
    Type: Application
    Filed: January 19, 2016
    Publication date: December 22, 2016
    Inventors: Masafumi Toyoshima, Carla Grandori
  • Patent number: 9273317
    Abstract: The invention generally relates to methods for identifying and using anticancer therapeutic agents and, more particularly, to methods for identifying and using inhibitors of genes for inhibiting the growth and/or proliferation of MYC-driven tumor cells relative to normal cells.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: March 1, 2016
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Masafumi Toyoshima, Carla Grandori
  • Publication number: 20150148401
    Abstract: The invention generally relates to methods for identifying and using anticancer therapeutic agents and, more particularly, to methods for identifying and using inhibitors of genes for inhibiting the growth and/or proliferation of MYC-driven tumor cells relative to normal cells.
    Type: Application
    Filed: August 9, 2012
    Publication date: May 28, 2015
    Applicant: Fred Huchinson Cancer Research Center
    Inventors: Masafumi Toyoshima, Carla Grandori
  • Publication number: 20130115309
    Abstract: In one aspect, the invention provides a method for inhibiting the growth and/or proliferation of a myc-driven tumor cell comprising the step of contacting the tumor cells with a CSNK1? inhibitor. In another aspect, the invention provides a method of treating a subject suffering from a tumor comprising myc-driven tumor cells, comprising administering to the subject an amount of a composition comprising a CSNK1? inhibitor effective to inhibit the growth and/or proliferation of the tumor cells.
    Type: Application
    Filed: April 6, 2011
    Publication date: May 9, 2013
    Applicant: FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: Carla Grandori, Masafumi Toyoshima